Sort   by:  
 Page size 
UnknownProtection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers.
Not available
S-EPMC9006784 | biostudies-literature
UnknownAssociation of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers.
Not available
S-EPMC9579910 | biostudies-literature
UnknownMyocarditis and myopericarditis cases following COVID-19 mRNA vaccines administered to 12-17-year olds in Victoria, Australia.
Not available
S-EPMC9240449 | biostudies-literature
UnknownSARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination.
Not available
S-EPMC9762734 | biostudies-literature
UnknownDeterminants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls.
Not available
S-EPMC10145209 | biostudies-literature
UnknownDoes coexisting accommodative dysfunction impact clinical convergence measures, symptoms and treatment success for symptomatic convergence insufficiency in children?
Not available
S-EPMC10544663 | biostudies-literature
UnknownEffects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study.
Not available
S-EPMC10156429 | biostudies-literature
UnknownClinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study.
Not available
S-EPMC9034855 | biostudies-literature
UnknownPost-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury.
Not available
S-EPMC10789589 | biostudies-literature
UnknownResidual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury.
Not available
S-EPMC12860639 | biostudies-literature
Sort   by:  
 Page size